Skip to Main Content

Paper Details

Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study.
4
2023
GLP-1RA, HbA, Semaglutide, T2D, Type 2 Diabetes, cholecystitis, diabetes, glucagon-like peptide 1 receptor, glycated haemoglobin, hypoglycaemia, insulin, metformin, participants, semaglutide, type 2 diabetes

Datasets

Release 1.2